Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Human Genome raises $200mm in convertible debt placement

Executive Summary

Human Genome Sciences Inc. (gene- and protein-based drugs) raised $150mm through the private placement of 5% subordinated notes due 2007. The notes are convertible into HGS common at $112.50 per share.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Convertible Debt

Related Companies

Advertisement
UsernamePublicRestriction

Register